Human metapneumovirus (hMPV), a member of the family Paramyxoviridae, is an important cause of acute respiratory tract disease. In the 1960s, vaccination with formalin-inactivated paramyxovirus preparations - respiratory syncytial virus (RSV) and measles virus (MV) - resulted in predisposition for enhanced disease upon natural infection. We have produced a formalin-inactivated hMPV preparation (FI-hMPV), which was used to immunize young cynomolgus macaques. Six days after challenge FI-hMPV-primed monkeys had developed eosinophilic bronchitis and bronchiolitis, indicative of a hypersensitivity response. This study indicates that formalin-inactivated hMPV vaccines have the same propensity to predispose for immune-mediated disease as inactivated RSV and MV vaccines.

Additional Metadata
Keywords Formaldehyde, Immunopathology, Paramyxovirus, Vaccination, hMPV
Persistent URL,
Journal Vaccine
de Swart, R.L, van den Hoogen, B.G, Kuiken, T, Herfst, S, van Amerongen, G, Yüksel, S, … Osterhaus, A.D.M.E. (2007). Immunization of macaques with formalin-inactivated human metapneumovirus induces hypersensitivity to hMPV infection. Vaccine, 25(51), 8518–8528. doi:10.1016/j.vaccine.2007.10.022